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Abstract
Introduction: The aim of this study was to assess variation in prostate
contouring 12 months following a structured interactive educational
intervention (EI) and to test the hypothesis that EIs positively impact on
prostate contouring accuracy and consistency long term. Methods: A common
set of computed tomography (CT) and magnetic resonance imaging (MRI)
data sets were used to assess prostate contouring consistency before,
immediately after and 12 months following an EI. No further EIs were
provided after the initial EI. Contour variation was assessed using the volume
ratio (VR), defined as the ratio of the encompassing volume to common
volume. Results: Of the original five radiation oncologists (ROs) at baseline,
four completed all assessments, and one was unavailable at 12 months follow-
up. At 12 months, mean VR deteriorated by 3.2% on CT and 1.9% on MRI
compared to immediately post EI. Overall, compared to the pre-EI baseline VR,
an improvement of 11.4% and 10.8% was demonstrated on CT and MRI,
respectively. Conclusion: Good retention of applied knowledge 12 months
following an EI on prostate contouring was demonstrated. This study advocates
for EIs to be included as part of continuing medical education to reduce
contour variation among ROs and improve knowledge retention long term.
Introduction
Recent advances in the delivery of radiation therapy (RT)
for clinically localised prostate cancer have enabled dose
escalation and greater sparing of organs at risk (OAR).1,2
To minimise radiation-induced toxicity to the rectum
and bladder neck, co-registration of magnetic resonance
imaging (MRI) with planning computed tomography
(CT) data sets has been incorporated into clinical practice
to improve soft tissue delineation.3–5
Due to normal anatomical variations, physiological
movement (internal motion) and inherent uncertainties
in patient positioning (setup error), RT to the prostate is
subject to inter- and intra-fraction variation. Planning
target volumes (PTV) are thus generated to account for
this uncertainty. Image-guided RT using intra-prostatic
fiducial markers can reduce inter-fractional treatment
variation and PTV margins6 while specialised systems
(e.g., Calypso extra-cranial tracking) can monitor
prostate motion during treatment to improve accuracy.7
Contouring variability is a major source of error in RT
delivery, having an impact on treatment accuracy similar
to organ motion and setup variation.8 Therefore, quality
assurance of target volume (TV) delineation among
radiation oncologists (ROs) is essential to improve
consistency. The co-registration of CT and MRI has been
shown to improve clinical target volume (CTV)
delineation and reduce inter-observer variability9 while
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dedicated anatomical and contouring education
interventions (EI) have been trialled.10
This study examines the longer term impact of an
education initiative (EI) to improve TV delineation by
ROs 12 months post EI. It is hypothesised that an EI
would positively impact prostate contouring in the long
term. This is a follow-up study to that reported by Khoo
et al.11
Methods and Materials
Contouring
This study is predominantly a quality assurance audit and
thus a request for waiver of Human Research Ethics
Committee review was approved by Oncology Research
Australia. The same three CT and MRI data sets used in
a previous report11 were again used for contouring and
consisted of three clinical scenarios: a patient with a small
prostate (42.5 cm3), large prostate (66.4 cm3) and a right
hip prosthesis. Four out of the five ROs from the
previous study contoured the entire prostate gland for
each patient on CT and MRI images. One participating
RO (‘RO4’) was unable to contribute due to work
relocation.
No further EIs were provided. The initial EI occurred
12 months prior and consisted of three formal
components. These consisted of a series of anatomy
lectures, completion of contouring modules using Prost-a-
doodle software12 and peer-review of contoured volumes.
For each patient, the prostate was contoured on the
planning CT data set, then on the MRI data set, without
referral back to the just completed contour on the CT
data set. The study schedule used in the EI is summarised
in Table 1.
The Philips Brilliance 16-slice CT scanner (Philips,
Cleveland, OH) with 1-mm slices and the GE Healthcare
1.5T, Excite Platform, eight-channel coil MRI scanner
(GE Healthcare, Milwaukee, WI) with T2-weighted
sequence with 2 mm slices were used. All data sets were
imported into the Eclipse treatment planning system
version 8.9 (Varian Medical Systems, Palo Alto, CA).
Coregistrations of CT and MRI data sets were based on
prostate fiducial markers. Neither the ROs previous
contours nor their colleagues’ contours were available
during any contouring session.
Analysis
Observer variation was measured as the ratio of
encompassing volume (EV) (the volume of the union of
a set of TVs) to common volume (CV, the volume of the
intersection of the same set of TVs)3 (See Fig. 1). This
metric is referred to as volume ratio (VR) and has also
been referred to as the Concordance Index in other
contouring analyses.10 For a set of identical TVs, VR is 1,
indicating no observer variation. As observer variation
increases, VR increases.
To determine intra-observer variation, the VR was
calculated for each RO, patient and imaging modality
from the TVs as contoured by the RO in each of the
2 months before, immediately following and 12 months
following the EI (see Table 2). Boolean analysis was used
to measure the degree of volume overlap for EV and CV.
The contour variation was assessed based on changes in
the VR. A comparison (percentage change) of VR before,
Table 1. Study schedule during the EI and subsequent follow-up.
Schedule Events
Duration of
each session Study
Month 1 Contouring on CT
data set first, then
MRI data set
consecutively for 3
patients
60–90 min Khoo
et al.11
Month 2 As per month 1 60–90 min
EI (1 session
per week
over 3 weeks)
Session 1: MRI
prostate anatomy
session
Session 2: MRI
prostate anatomy
session
Session 3: Practical
session
60 min each
Month 3 As per month 1 60–90 min
Month 4 As per month 1 60–90 min
Month 12 As per month 1 60–90 min Current
study
CT, computed tomography; MRI, magnetic resonance imaging;
EI, education intervention.
Figure 1. Volume ratio (VR) = encompassing volume (EV)/common
volume (CV).
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immediately after and 12 months after the EI was
determined. Due to the small sample size, descriptive
statistics are presented without formal inference. Inter-
observer contour variation was not calculated.
Results
Prostate contours at the mid-gland level on CT and MRI
images are outlined in Figure 2. The VR was stable for
three ROs, however, VR regressed back to its level prior
to the EI for one participant. The VR measurements were
better for MRI contoured volumes compared to CT.
There was a differential impact of the EI among ROs.
For the CT data set, the mean VR of the 4 ROs after the
EI and at 12 month follow-up was 1.31, 1.32, 1.40, 1.25
and 1.26, 1.31, 1.66, 1.25, respectively. For the MRI data
set, the mean VR after the EI and at 12 months was 1.14,
1.16, 1.18, 1.14 and 1.16, 1.12, 1.26, 1.18, respectively.
The mean VRs for each RO for CT and MRI data sets
and various follow-up times are displayed in Table 2 and
Figure 3.
Mean VR measured after the EI compared to
12 month follow-up for all ROs deteriorated by 3.2%
(CT) and 1.9% (MRI) respectively. Overall, there is an
Table 2. Individual and mean intra-observer VR before, immediately
after and 12 months following the EI for computed tomography and
magnetic resonance imaging modalities.
Parameter Education RO1 RO2 RO3 RO5 Mean VR
CT CTV Before 1.44 1.43 1.99 1.32 1.55
After 1.31 1.32 1.4 1.25 1.32
12 months 1.26 1.31 1.66 1.25 1.37
MRI CTV Before 1.19 1.18 1.46 1.46 1.32
After 1.14 1.16 1.18 1.14 1.16
12 months 1.16 1.12 1.26 1.18 1.18
VR, volume ratio; CT, computed tomography; CTV, clinical target
volume; MRI, magnetic resonance imaging; EI, education intervention.
Figure 2. Prostate contouring at the mid-gland level on computed tomography and magnetic resonance imaging demonstrating variability in
target volume delineation between four radiation oncologists for patients 1 (above) and 3 (below).
Figure 3. Mean intra-observer volume ratio before, immediately after
and 12 months following the education intervention for (A)
computed tomography and (B) magnetic resonance imaging
modalities.
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improvement of 11.4% (CT) and 10.8% (MRI) from the
baseline VR calculated prior to the EI. The mean intra-
observer VR averaged over all ROs and patients is shown
in Figure 4 suggesting good retention over time.
Discussion
Intra- and inter-observer contouring variability is well
described not only in localised prostate, but also for
lung,13 head and neck14 and breast cancers.15 Despite no
widely accepted method of systematic contour
comparison, volume-based metrics are the most
frequently used assessment parameter.10 Our updated
data 12 months following an EI to improve prostate
contouring suggests that retention of knowledge is
maintained over time.
To our knowledge, this is the first study to assess the
long-term impact of a structured EI on prostate
contouring for ROs. This analysis focuses on knowledge
and skill retention and has demonstrated an ongoing
reduction in intra-observer contour variation following a
structured and interactive EI. While the mean VR
12 months after the EI deteriorated as a group compared
to immediately after, the improvement from baseline was
significant. This impact was greater on CT than MRI
volumes.
This study contributes to the existing literature and
provides additional insights into prostate contouring
variability. Fiorino et al.16 demonstrated a 10–18% inter-
and 5% intra-observer variability in prostate volume
contouring and Nakamura et al.17 exposed a wide variety
of prostate volume definition among Japanese ROs. Gao
et al.18 compared prostate gland delineations to images
from the Visible Human Project and revealed that
observers consistently underestimated the posterior
portion of the prostate gland. This may have clinical
implications as these observers may be inadvertently
omitting the peripheral zone of the prostate, a region in
which 70% of prostate adenocarcinoma develops.
Retention of acquired knowledge by health care
professionals is a high priority across different disciplines.
After 1 year, only 60–70% of knowledge is retained while
skill sets appear to deteriorate more rapidly.19,20 In our
study, this inherent decay was most striking in RO3, who
improved initially with the group, but subsequently
returned to an earlier pattern of prostate contour over-
estimation. Various institutions and training bodies
acknowledge this phenomena and mandate regular
re-training to maintain competency as repeated retrieval
of information is crucial to long-term retention. For
example resuscitation councils worldwide traditionally
recommend healthcare providers receive Advanced Life
Support retraining or refresher course at least every
2 years.20 Recertification in RO contouring may be
necessary to ensure quality compliance over time in an
effort to reduce clinician error. Currently, no formal
contouring recertification is required for radiation
oncology fellows of the Royal Australian and New
Zealand College of Radiologists (RANZCR).
Given the potential adverse clinical sequelae of CTV
variation on patient outcomes, there has been a
significant shift in contouring teaching and assessment.
The American Society for Radiation Oncology (ASTRO)
and the European Society for Radiotherapy and Oncology
(ESTRO) both have established contouring programmes
across multiple tumour streams. ASTRO have recently
incorporated online contouring programmes in its annual
meeting and are now presenting an ‘eContouring’
programme for radiation oncology trainees. Common
among these programmes, participants can assess their
own contour variability and compare their volumes to
those of the instructor and their peers. The Canadian
Association of Radiation Oncology (CARO) has recently
trialled a contouring ‘boot camp’ with promising
results.21 It has been shown that interactive workshops
similar to those mentioned above result in significant
changes in clinical practice as opposed to didactic
sessions alone.22 There is currently no formal contouring
training by the faculty of radiation oncology of RANZCR,
however, close links with ESTRO are established.
Other means of improving contour variation include
the use of published contouring atlases, institutional
protocols, peer review of positron emission tomography
(PET) or MRI image fusion and regular contouring
quality assurance between radiation oncology
departments. Intra- and inter-observer variation in TV
delineation has been shown to be reduced by
implementing a departmental, national or international
protocol.23,24 The incorporation of a ‘refresher note’ into
these protocols, a document outlining common
contouring pitfalls and errors, may also play a role. The
increasing practice of site specific weekly contouring
quality assurance meetings in which RO contouring is
peer reviewed prior to dosimetric planning appear to be a
Figure 4. Mean intra-observer volume ratio before, immediately after
and 12 months following the education intervention averaged for all
radiation oncologists and patients.
158 ª 2016 The Authors. Journal of Medical Radiation Sciences published by John Wiley & Sons Australia, Ltd on behalf of
Australian Institute of Radiography and New Zealand Institute of Medical Radiation Technology
Maintaining Prostate Contouring Consistency L. Nicholls et al.
sound way forward in terms of increasing the consistency
amongst ROs. Moreover, this provides a valuable
educational forum for trainees.
The limitations of this single institution study include
small sample size, loss of follow-up of one original
participating RO and the absence of a control or gold
standard group. The absence of a gold standard contour
makes it impossible to make conclusions about the
absolute accuracy of contours. The choice of this gold
standard or reference contour varies in the literature
from a mathematical average contour, an RO- or
radiologist-defined contour, or a consensus contour that
is decided upon by a panel of experts.10 The contour data
sets from the previous study were lost due to an upgrade
of the radiation treatment planning system in the
department. However, our study used the same concept
of VR methodology and the comparison between VR pre-
, post- and 12 months following the EI remains valid.
Lastly, data on the frequency of prostate contouring for
each of the ROs were not formally assessed. All ROs in
this study regularly treat localised prostate cancer,
however, absolute patient numbers treated were not
available. Regular prostate contouring would appear to be
the most robust way of consolidating contouring
knowledge and may explain the variation amongst the
ROs in the study.
Possible follow-up studies in this domain could assess
the significance between RO prostate contouring
consistency and the number of localised prostate cancers
treated per year. Furthermore, studies randomising ROs
to an EI versus no EI, assessing contouring consistency in
other tumour sites and assessing the required frequency
of EIs to maximise knowledge retention over time may
lead to further gains in contouring quality assurance.
Conclusion
Contour variation impacts the accuracy of RT as
significantly as organ motion and setup variability. Novel
methods to improve contouring consistency should be
rigorously pursued to match recent technological
advancements in RT delivery. This contouring audit has
shown that 12 months following a structured EI
consisting of anatomy tutorials, contouring modules and
peer review, adequate retention of knowledge and
subsequent improvement in contouring consistency was
demonstrated in a small cohort of ROs treating localised
prostate cancer. The improvements in contour
consistency achieved herein advocate for EIs to be
included as part of continuing medical education for ROs
treating localised prostate cancer. Further studies are
required to further define the frequency with which such
EI should be incorporated into clinical practice.
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